Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the USKrista F. Huybrechts, Helle Kieler, Helga Zoëga et al.|JAMA Psychiatry|2022Cited by 70
A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS)Jacqueline M. Cohen, Vidar Hjellvik, Carolyn E. Cesta et al.|Norsk Epidemiologi|2021Cited by 25
Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019Pär Karlsson, Carolyn E. Cesta, Karin Gembert et al.|Pharmacoepidemiology and Drug Safety|2024Cited by 3
The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort studyKrista F. Huybrechts, Helle Kieler, Loreen Straub et al.|STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)|2021Cited by 0